STOCK TITAN

Merck (MRK) EVP David Maraldo granted options and RSUs, updates holdings

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Merck & Co., Inc. executive David R. Maraldo reported new equity awards and updated holdings. As EVP & Pres. MMD, he received a grant of stock options for 21,731 shares of common stock at an exercise price of $113.15 per share, vesting in three equal installments on 5/5/2027, 5/5/2028, and 5/5/2029. He also received 7,424 restricted stock units, each representing a contingent right to one Merck common share, vesting and settling in three equal installments on those same dates. Following these transactions, he reports direct ownership of 18,212.434 shares of common stock and indirect ownership of 8,359.14 shares through a 401(k) plan.

Positive

  • None.

Negative

  • None.
Insider Maraldo David R.
Role EVP & Pres. MMD
Type Security Shares Price Value
Grant/Award Restricted Stock Unit 7,424 $0.00 --
Grant/Award Stock Option (Right to Buy) 21,731 $0.00 --
holding Common Stock -- -- --
holding Common Stock - 401(k) Plan -- -- --
Holdings After Transaction: Restricted Stock Unit — 7,424 shares (Direct, null); Stock Option (Right to Buy) — 21,731 shares (Direct, null); Common Stock — 18,212.434 shares (Direct, null); Common Stock - 401(k) Plan — 8,359.14 shares (Indirect, By 401 (k))
Footnotes (1)
  1. Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. The option vests and becomes exercisable in equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029.
Stock options granted 21,731 shares Stock Option (Right to Buy) granted on 5/5/2026
Option exercise price $113.15/share Conversion or exercise price for 21,731 stock options
Option vesting period 5/5/2027–5/5/2029 Options vest in three equal annual installments
RSUs granted 7,424 units Restricted Stock Unit award on 5/5/2026
RSU vesting dates 5/5/2027, 5/5/2028, 5/5/2029 RSUs vest and distribute in three equal installments
Direct common stock held 18,212.434 shares Total shares following transaction, direct ownership
401(k) common stock held 8,359.14 shares Total shares following transaction, indirect via 401(k) plan
Restricted Stock Unit financial
"Restricted Stock Unit ... represents a contingent right to receive one share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with an exercise price of $113.15"
401(k) Plan financial
"Common Stock - 401(k) Plan held indirectly by 401(k)"
A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.
exercise price financial
"conversion_or_exercise_price of 113.1500 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"These restricted stock units vest and are distributed in three equal installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Maraldo David R.

(Last)(First)(Middle)
126 EAST LINCOLN AVENUE

(Street)
RAHWAY NEW JERSEY 07065

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Merck & Co., Inc. [ MRK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP & Pres. MMD
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/05/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock18,212.434D
Common Stock - 401(k) Plan8,359.14IBy 401 (k)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(1)05/05/2026A7,42405/05/2027(2)05/05/2029Common Stock7,424$07,424D
Stock Option (Right to Buy)$113.1505/05/2026A21,73105/05/2027(3)05/04/2036Common Stock21,731$021,731D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
2. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029.
3. The option vests and becomes exercisable in equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029.
/s/ Kelly E. W. Grez as Attorney-in-Fact for David R. Maraldo05/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Merck (MRK) executive David R. Maraldo report in this Form 4?

David R. Maraldo reported new equity awards and updated share holdings. He received stock options and restricted stock units that vest over three years, and disclosed current direct and indirect ownership in Merck common stock, including shares held in a 401(k) plan.

How many Merck (MRK) stock options were granted to David R. Maraldo?

He received stock options for 21,731 shares of Merck common stock. These options have an exercise price of $113.15 per share and vest in three equal installments on 5/5/2027, 5/5/2028, and 5/5/2029, if service-based conditions are met.

What restricted stock unit (RSU) award did Maraldo receive from Merck (MRK)?

He received 7,424 restricted stock units, each representing a contingent right to one Merck common share. The RSUs vest and are distributed in three equal installments on 5/5/2027, 5/5/2028, and 5/5/2029, according to the footnote disclosure.

When do David R. Maraldo’s new Merck (MRK) equity awards vest?

Both the stock options and restricted stock units vest over three years. Vesting occurs in equal installments on 5/5/2027, 5/5/2028, and 5/5/2029, with options becoming exercisable and RSUs converting into Merck common shares on those dates.

What are David R. Maraldo’s Merck (MRK) share holdings after these transactions?

After these transactions, he reports direct ownership of 18,212.434 Merck common shares. He also reports indirect ownership of 8,359.14 shares through a 401(k) plan, providing a view of both personally held and retirement-plan holdings as of the transaction date.

Are Maraldo’s new Merck (MRK) awards open-market purchases or compensation grants?

The filing characterizes them as compensation-related grants. Transaction code A and descriptions show they are grants or awards of stock options and restricted stock units, rather than open-market purchases or sales of Merck common stock.